{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:14Z","timestamp":1786997894505,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation (BMGF)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T01:30:12Z","timestamp":1510709412000},"page":"7283-7291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules"],"prefix":"10.1016","volume":"35","author":[{"given":"Ananda S.","family":"Bandyopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J.","family":"Asturias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"O'Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"R\u00fcttimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Gast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.11.006_b0005","unstructured":"Global Polio Eradication Initiative. Polio this week as of 15 February 2017. http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/ [accessed 16.02.17]."},{"key":"10.1016\/j.vaccine.2017.11.006_b0010","unstructured":"Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013-2018. Geneva, Switzerland: World Health Organization; 2013. http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf [accessed 16.02.17]."},{"key":"10.1016\/j.vaccine.2017.11.006_b0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2017.11.006_b0020","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.162.8.5011","article-title":"Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus","volume":"162","author":"Herremans","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.11.006_b0025","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/infdis\/jit671","article-title":"Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination","volume":"209","author":"Wright","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0030","doi-asserted-by":"crossref","unstructured":"Dey A, Molodecky NA, Verma H, et al. Human circulating antibody-producing B cell as a predictive measure of mucosal immunity to poliovirus. PLoS One 2016; 11: e 0146010.","DOI":"10.1371\/journal.pone.0146010"},{"key":"10.1016\/j.vaccine.2017.11.006_b0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"10.1016\/j.vaccine.2017.11.006_b0040","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S1473-3099(16)30169-4","article-title":"Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants","volume":"16","author":"Wright","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0045","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1473-3099(15)00219-4","article-title":"Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study","volume":"15","author":"O'Ryan","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1473-3099(15)00488-0","article-title":"Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial","volume":"16","author":"S\u00e1ez-Llorens","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.11.006_b0060","doi-asserted-by":"crossref","unstructured":"Wood SN. Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models. J Royal Stat Soc (B) 2011; 7(1)3: p. 3\u201336.","DOI":"10.1111\/j.1467-9868.2010.00749.x"},{"key":"10.1016\/j.vaccine.2017.11.006_b0065","unstructured":"R Development Core Team, 2016. R: a language and environment for statistical computing, ed. R Foundation for Statistical Computing, Vienna, Austria. Available at: https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.vaccine.2017.11.006_b0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"10.1016\/j.vaccine.2017.11.006_b0075","unstructured":"Roger Koenker. quantreg: Quantile Regression. R package version 5.29. https:\/\/CRAN.R-project.org\/package=quantreg; 2016."},{"key":"10.1016\/j.vaccine.2017.11.006_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2307\/1912528","article-title":"Robust tests for heteroscedasticity based on regression quantiles","volume":"50","author":"Koenker","year":"1982","journal-title":"Econometrica"},{"key":"10.1016\/j.vaccine.2017.11.006_b0085","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1080\/01621459.1999.10473882","article-title":"Goodness of fit and related inference processes for quantile regression","volume":"94","author":"Koenker","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2017.11.006_b0090","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","author":"Verdijk","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.006_b0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0100","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S1473-3099(16)30371-1","article-title":"Unravelling mucosal immunity to poliovirus","volume":"16","author":"Parker","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2105\/AJPH.48.9.1181","article-title":"The influence of natural and artificially induced immunity on alimentary infections with polioviruses","volume":"48","author":"Fox","year":"1958","journal-title":"Am J Public Health Nations Health"},{"key":"10.1016\/j.vaccine.2017.11.006_b0110","first-page":"1","article-title":"The quantitation of poliomyelitis virus in the human alimentary tract with reference to coexisting levels of homologous serum neutralizing antibody","volume":"75","author":"Howe","year":"1962","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2017.11.006_b0115","first-page":"173","article-title":"Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic","volume":"76","author":"Marine","year":"1962","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2017.11.006_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/oxfordjournals.aje.a120578","article-title":"Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1","volume":"83","author":"Glezen","year":"1966","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.11.006_b0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0022172400040389","article-title":"A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living polio vaccine","volume":"64","author":"Henry","year":"1966","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2017.11.006_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhanced potency IPV and OPV","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.11.006_b0135","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1093\/clinids\/6.Supplement_2.S361","article-title":"Mucosal immune response to poliovirus vaccines in childhood","volume":"6","author":"Ogra","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-1157(84)80015-3","article-title":"The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years","volume":"12","author":"Nishio","year":"1984","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2017.11.006_b0145","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/jis241","article-title":"Waning intestinal immunity after vaccination with oral poliovirus vaccines in India","volume":"205","author":"Grassly","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0150","first-page":"529","article-title":"The duration of intestinal immunity after an inactivated poliovirus vaccine booster dose in children immunized with oral vaccine: a randomized controlled trial","volume":"215","author":"John","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijid.2013.09.005","article-title":"A quantitative survey of the literature on poliovirus infection and immunity","volume":"18","author":"Behrend","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0160","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/162.6.1291","article-title":"Comparative evaluation of immunization with live attenuated and enhanced potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses","volume":"162","author":"Faden","year":"1990","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.11.006_b0165","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/175.Supplement_1.S228","article-title":"Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules","volume":"175","author":"Modlin","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0170","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"Cuba IPV Study Collaborative Group","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.11.006_b0175","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.vaccine.2017.11.006_b0180","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(15)00237-8","article-title":"Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial","volume":"386","author":"Sutter","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.11.006_b0185","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1956.02970350005002","article-title":"Present status of attenuated live-virus poliomyelitis vaccine","volume":"162","author":"Sabin","year":"1956","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2017.11.006_b0190","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.006_b0195","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/605330","article-title":"Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India","volume":"200","author":"Grassly","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.006_b0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/oxfordjournals.aje.a120717","article-title":"Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter","volume":"86","author":"Benyesh-Melnick","year":"1967","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.11.006_b0205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T10:28:11Z","timestamp":1693218491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17315487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17315487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}